TERM ID="NYU_TERM_1" STRING="6MP" FREQUENCY=5 START=885 END=888 LEMMA="6 MERCAPTOPURINE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_2" STRING="6MP" FREQUENCY=5 START=1131 END=1134 LEMMA="6 MERCAPTOPURINE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_3" STRING="6MP" FREQUENCY=5 START=1234 END=1237 LEMMA="6 MERCAPTOPURINE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_4" STRING="6MP" FREQUENCY=5 START=1392 END=1395 LEMMA="6 MERCAPTOPURINE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_5" STRING="6MP" FREQUENCY=5 START=1659 END=1662 LEMMA="6 MERCAPTOPURINE" LEMMA_FREQUENCY=5
TERM ID="NYU_TERM_6" STRING="ASP" FREQUENCY=5 START=838 END=841 LEMMA="ASPARAGINASE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_7" STRING="ASP" FREQUENCY=5 START=944 END=947 LEMMA="ASPARAGINASE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_8" STRING="ASP" FREQUENCY=5 START=1141 END=1144 LEMMA="ASPARAGINASE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_9" STRING="ASP" FREQUENCY=5 START=1244 END=1247 LEMMA="ASPARAGINASE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_10" STRING="ASP" FREQUENCY=5 START=1676 END=1679 LEMMA="ASPARAGINASE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_11" STRING="ASP trial" FREQUENCY=1 START=1442 END=1451 LEMMA="ASP TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="Age-dependent participation rates" FREQUENCY=1 START=472 END=505 LEMMA="AGE-DEPENDENT PARTICIPATION RATE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="Dx/VCR" FREQUENCY=4 START=691 END=697 LEMMA="DX/VCR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_14" STRING="Dx/VCR" FREQUENCY=4 START=1110 END=1116 LEMMA="DX/VCR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_15" STRING="Dx/VCR" FREQUENCY=4 START=1213 END=1219 LEMMA="DX/VCR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_16" STRING="Dx/VCR" FREQUENCY=4 START=1365 END=1371 LEMMA="DX/VCR" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_17" STRING="Lymphoblastic Leukemia Trials" FREQUENCY=1 START=89 END=118 LEMMA="LYMPHOBLASTIC LEUKEMIA TRIAL" LEMMA_FREQUENCY=1
ORGANIZATION ID="NYU_ID_18" STRING="Nordic Society" START=582 END=596
TERM ID="NYU_TERM_19" STRING="Nordic Society of Paediatric Haematology" FREQUENCY=1 START=582 END=622 LEMMA="PAEDIATRIC HAEMATOLOGY NORDIC SOCIETY" LEMMA_FREQUENCY=1 HEAD_TERM="Nordic Society" HEAD_LEMMA="NORDIC SOCIETY"
TERM ID="NYU_TERM_20" STRING="Oncology" FREQUENCY=1 START=627 END=635 LEMMA="ONCOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="PEG-asparaginase" FREQUENCY=1 START=820 END=836 LEMMA="PEG-ASPARAGINASE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_22" STRING="Paediatric Haematology" FREQUENCY=1 START=600 END=622 LEMMA="PAEDIATRIC HAEMATOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="Patient randomization" FREQUENCY=1 START=950 END=971 LEMMA="PATIENT RANDOMIZATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="Reduced Treatment" FREQUENCY=1 START=57 END=74 LEMMA="REDUCED TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="asparaginase" FREQUENCY=1 START=824 END=836 LEMMA="ASPARAGINASE" LEMMA_FREQUENCY=6
TERM ID="NYU_TERM_26" STRING="back-to-back" FREQUENCY=1 START=764 END=776 LEMMA="BACK-TO-BACK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="clinical trials" FREQUENCY=1 START=149 END=164 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="consent process" FREQUENCY=1 START=1907 END=1922 LEMMA="CONSENT PROCESS" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_29" STRING="consolidation treatment" FREQUENCY=1 START=1519 END=1542 LEMMA="CONSOLIDATION TREATMENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_30" STRING="dexamethasone/vincristine" FREQUENCY=2 START=664 END=689 LEMMA="DEXAMETHASONE/VINCRISTINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_31" STRING="dexamethasone/vincristine" FREQUENCY=2 START=664 END=689 LEMMA="DEXAMETHASONE/VINCRISTINE" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_32" STRING="enrollment patterns" FREQUENCY=1 START=379 END=398 LEMMA="ENROLLMENT PATTERN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_33" STRING="favored treatment intensifications" FREQUENCY=1 START=1074 END=1108 LEMMA="FAVORED TREATMENT INTENSIFICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="inclinations" FREQUENCY=1 START=1782 END=1794 LEMMA="INCLINATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="intensification trials" FREQUENCY=1 START=1293 END=1315 LEMMA="INTENSIFICATION TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="involving adolescents" FREQUENCY=1 START=1869 END=1890 LEMMA="INVOLVING ADOLESCENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_37" STRING="median consolidation length" FREQUENCY=1 START=1560 END=1587 LEMMA="MEDIAN CONSOLIDATION LENGTH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_38" STRING="offered participation" FREQUENCY=1 START=124 END=145 LEMMA="OFFERED PARTICIPATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_39" STRING="randomized childhood leukemia trials" FREQUENCY=1 START=528 END=564 LEMMA="RANDOMIZED CHILDHOOD LEUKEMIA TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="tested treatment intensifications" FREQUENCY=2 START=705 END=738 LEMMA="TESTED TREATMENT INTENSIFICATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_41" STRING="tested treatment intensifications" FREQUENCY=2 START=850 END=883 LEMMA="TESTED TREATMENT INTENSIFICATION" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_42" STRING="toxicity profiles" FREQUENCY=1 START=453 END=470 LEMMA="TOXICITY PROFILE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="toxicity reduction" FREQUENCY=1 START=894 END=912 LEMMA="TOXICITY REDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="treatment reductions" FREQUENCY=1 START=1191 END=1211 LEMMA="TREATMENT REDUCTION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="trial participation" FREQUENCY=1 START=1962 END=1981 LEMMA="TRIAL PARTICIPATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="varying effect size" FREQUENCY=1 START=1458 END=1477 LEMMA="VARYING EFFECT SIZE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="vice versa" FREQUENCY=1 START=1710 END=1720 LEMMA="VICE VERSA" LEMMA_FREQUENCY=1
